[1] |
LI Mingying, ZHANG Xiaoxia, SUN Xiaoli, ZHAO Yan, HE Miao, LI Yanling, DUAN Wei, YANG Ou.
Effect of Sugammadex on Recovery of Patients after Laparoscopic Total Pelvic Floor Reconstruction
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 896-901.
|
[2] |
KE Xiuqin, HAI Xuewu.
433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927.
|
[3] |
LIANG Jie.
172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932.
|
[4] |
LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji.
Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936.
|
[5] |
ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing.
Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940.
|
[6] |
ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng.
Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943.
|
[7] |
CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing.
One Case of Acute Withdrawal Syndrome Caused by Naloxone
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946.
|
[8] |
YANG Xin, YANG Baochun, YANG Yang, SHAO Huan.
One Case of Multiple Endocrine Adverse Effect Caused by Sintilimab
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 947-949.
|
[9] |
WANG Chunting, CHEN Yafei.
Considerations for Revision of Safety Information in the Post-Marketing Instructions of Chemical Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 776-779.
|
[10] |
ZHU Huijuan, REN Jingtian.
Safety Risks of Human Rabies Immunoglobulin
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 786-789.
|
[11] |
CHEN Yaozhe, ZHAN Yunli, SONG Xingdong, ZHU Manyu, OU Xuemei, LI Chuyun.
48 Cases of Hematological Adverse Reactions Associated with Piperacillin Sodium and Tazobactam Sodium
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 794-798.
|
[12] |
CAO Kai, QIAN Peipei, GAO Xin, YANG Futian, ZHAO Liang, XU Bingxin, ZHANG Xianjun.
Mining of Risk Signals Adverse Events Related to Drug-Induced Salivary Gland Calculus Based on FAERS Database
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 799-804.
|
[13] |
LIN Lu, ZHAO Anzhi, CHEN Jinhui, LI Zhongwen, HUANG Guohua, ZHONG Shilong.
One Case of Delayed Hypersensitivity Reactions Caused by Cefotaxime Sodium and Sulbactam Sodium for Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 809-811.
|
[14] |
TANG Jiong, ZENG Yuqi.
One Case of Oculomotor Paralysis Caused by Sugemalimab Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 812-814.
|
[15] |
WANG Yuan, LI Ruoning, GUO Zhanli, ZHANG Lei, LI Jiayuan, DONG Ying, SUN Jianjun.
One Case of Extremely Severe Thrombocytopenia Caused by Tirofiban Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 815-818.
|